Transfer of aspartyl dipeptide in Hatcho Miso into blood and blood pressu re variability

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1051230143

Enrollment

Registered

2023-12-13

Start date

2023-12-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Group A: 1st Miso

take 18 g orally with 180ml of hot water. 2nd Salt

take 2g orally with 180 ml of hot water. Group B: 1st Salt

take 2g orally with 180 ml of hot water. 2nd Miso

take 18 g orally with 180ml of hot water.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy subjects

Exclusion criteria

Exclusion criteria: Those who are undergoing regular medical examinations by a physician for hypertension, arrhythmia, or renal disease. Pregnant or possibly pregnant. Those who are breast-feeding. Those who are allergic to soybeans. Those who the principal investigator or research coordinator determines to be inappropriate to conduct this study.

Design outcomes

Primary

Measure	Time frame
Aspartyl dipeptide concentration before and and after ingestion of Hatcho Miso	—

Secondary

Measure	Time frame
Blood pressure, plasma renin activity and aldosterone levels, aspartyl dipeptide concentration before and after ingestion of salt, and safety	—

Contacts

Public ContactYoko Ueba

Kyoto University Graduate School of Medicine

yokoueba@kuhp.kyoto-u.ac.jp+81-75-751-3560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026